BB MPI 03

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBB MPI 03
Drug Alias NameBB-MPI-03OFA multi-peptide immunotherapy - Benovus-BioOFA multi-peptide cancer vaccine - Benovus BioiLRP multi-peptide cancer vaccine - Benovus BioOncofetal antigen multi-peptide cancer vaccine - Benovus Bio +[8] 
ClassificationBiologics > Antigen > Tumor antigenBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesSmoldering Multiple MyelomaMultiple Myeloma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBenovus Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBenovus Bio Inc
Active IndicationsN/A
Inactive IndicationsMyelodysplastic SyndromesSmoldering Multiple MyelomaMultiple Myeloma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A